Paul J Kurtin Selected Research

Peptides (Polypeptides)

8/2017	Acquired transthyretin amyloidosis after domino liver transplant: Phenotypic correlation, implication of liver retransplantation.
2/2017	Novel Type of Renal Amyloidosis Derived from Apolipoprotein-CII.
2/2017	Hereditary Lysozyme Amyloidosis Variant p.Leu102Ser Associates with Unique Phenotype.
4/2015	Proteomic detection of immunoglobulin light chain variable region peptides from amyloidosis patient biopsies.
1/2015	Upper Gastrointestinal Bleeding from Gastric Amyloidosis in a Patient with Smoldering Multiple Myeloma.
7/2014	Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics.
5/2014	Clinical proteome informatics workbench detects pathogenic mutations in hereditary amyloidoses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul J Kurtin Research Topics

Disease

27	Amyloidosis 01/2023 - 02/2004
15	Neoplasms (Cancer) 01/2020 - 11/2002
14	Amyloid Plaque 01/2023 - 03/2014
11	Lymphoma (Lymphomas) 01/2022 - 06/2002
9	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2018 - 01/2002
5	Familial Amyloidosis (Hereditary Amyloidosis) 11/2018 - 05/2014
4	Immunoglobulin Light-chain Amyloidosis 01/2023 - 03/2014
4	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2011 - 07/2004
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020 - 01/2002
3	Glomerulonephritis 01/2017 - 05/2015
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2011 - 06/2006
2	Carcinoma (Carcinomatosis) 10/2019 - 02/2005
2	Transthyretin-Related Hereditary Amyloidosis 08/2017 - 07/2014
2	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2017 - 06/2016
2	Chronic Renal Insufficiency 01/2017 - 01/2016
2	Autoimmune Diseases (Autoimmune Disease) 06/2016 - 11/2005
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2016 - 08/2006
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2015 - 11/2002
2	Thrombocytopenia (Thrombopenia) 04/2011 - 08/2008
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2011 - 04/2003
2	T-Cell Lymphoma (Lymphoma, T Cell) 08/2008 - 08/2006
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 12/2006 - 07/2002
1	Splenomegaly 01/2023
1	Splenic Rupture 01/2023
1	Hodgkin Disease (Hodgkin's Disease) 01/2022
1	Deafness (Deaf Mutism) 09/2020
1	Sensorineural Hearing Loss 09/2020
1	Cardiac Arrhythmias (Arrythmia) 01/2020
1	Acinar Cell Carcinoma 01/2020
1	Stroke (Strokes) 01/2020
1	Atrial Fibrillation 01/2020
1	Multiple Myeloma 10/2019
1	Sepsis (Septicemia) 10/2019
1	Acute Kidney Injury (Acute Renal Failure) 10/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 11/2018
1	Heart Failure 11/2018
1	Systemic Mastocytosis 10/2018
1	Eosinophilia 10/2018
1	Pdgfra-Associated Chronic Eosinophilic Leukemia 10/2018
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 10/2018

Drug/Important Bio-Agent (IBA)

21	Amyloid (Amyloid Fibrils)IBA 01/2023 - 02/2004
12	Congo RedIBA 01/2023 - 01/2013
12	Proteins (Proteins, Gene)FDA Link 03/2022 - 06/2006
9	Rituximab (Mabthera)FDA Link 10/2017 - 01/2002
9	ParaffinIBA 04/2015 - 01/2002
7	Peptides (Polypeptides)IBA 08/2017 - 05/2014
5	Immunoglobulins (Immunoglobulin)IBA 10/2019 - 07/2014
4	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2023 - 07/2014
4	Chemotactic FactorsIBA 01/2023 - 03/2014
3	GelsolinIBA 11/2018 - 01/2013
3	AntibodiesIBA 04/2005 - 01/2002
3	AntigensIBA 04/2005 - 09/2002
2	Fibrinogen (Factor I)FDA Link 01/2023 - 05/2014
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2008
2	Carboxypeptidases A (Carboxypeptidase A)IBA 01/2020 - 10/2019
2	AA amyloidosisIBA 10/2019 - 04/2016
2	Mutant Proteins (Protein, Mutant)IBA 11/2018 - 09/2018
2	IgKIBA 11/2018 - 12/2006
2	Apolipoprotein C-II (ApoC2)IBA 09/2018 - 02/2017
2	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2017 - 10/2011
2	PlatinumIBA 10/2017 - 06/2008
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2017 - 10/2011
2	apolipoprotein A-IV (apolipoprotein AIV)IBA 01/2017 - 01/2016
2	Complement System Proteins (Complement)IBA 01/2017 - 06/2016
2	ParaproteinsIBA 06/2016 - 06/2009
2	ApolipoproteinsIBA 01/2016 - 01/2013
2	Immunoglobulin M (IgM)IBA 05/2015 - 04/2003
2	Immunoglobulin G (IgG)IBA 05/2015 - 06/2009
2	Formaldehyde (Formol)FDA Link 04/2015 - 05/2014
2	ProteomeIBA 07/2014 - 05/2014
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2011 - 10/2011
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2011 - 10/2011
2	Vincristine (Oncovin)FDA LinkGeneric 10/2011 - 10/2011
2	TOR Serine-Threonine KinasesIBA 04/2011 - 08/2008
2	temsirolimus FDA Link 04/2011 - 08/2008
2	CytokinesIBA 07/2007 - 11/2005
2	Interleukin-12 (IL 12)IBA 10/2006 - 01/2002
2	ChemokinesIBA 08/2006 - 11/2002
2	ClusterinIBA 02/2005 - 08/2004
1	Coloring Agents (Dyes)IBA 01/2023
1	N 30IBA 01/2023
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 03/2022
1	Lymphoid Enhancer-Binding Factor 1IBA 01/2022
1	CateninsIBA 01/2022
1	Epidermal Growth Factor (EGF)IBA 02/2021
1	Extracellular Matrix ProteinsIBA 02/2021
1	fibulinIBA 02/2021
1	EnzymesIBA 01/2020
1	Adenosine Monophosphate (AMP)IBA 01/2020
1	AnthracyclinesIBA 11/2018
1	Prealbumin (Transthyretin)IBA 11/2018
1	Diflunisal (Dolobid)FDA Link 10/2018
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 10/2018
1	Tryptases (Tryptase)IBA 10/2018

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 10/2019 - 02/2004
6	Lasers (Laser) 10/2019 - 01/2013
6	Therapeutics 01/2016 - 04/2003
2	Splenectomy 01/2023 - 04/2005
2	Radiotherapy 10/2019 - 10/2011
1	Maze Procedure 01/2020